Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)-Reference-Cited by-同舟云学术

Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

Published:2015-03 Issue:9972 Volume:385 Page:977-1010
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Allemani Claudia,Weir Hannah K,Carreira Helena,Harewood Rhea,Spika Devon,Wang Xiao-Si,Bannon Finian,Ahn Jane V,Johnson Christopher J,Bonaventure Audrey,Marcos-Gragera Rafael,Stiller Charles,Azevedo e Silva Gulnar,Chen Wan-Qing,Ogunbiyi Olufemi J,Rachet Bernard,Soeberg Matthew J,You Hui,Matsuda Tomohiro,Bielska-Lasota Magdalena,Storm Hans,Tucker Thomas C,Coleman Michel P

Publisher

Elsevier BV

Subject

General Medicine

Reference128 articles.

1. Global cancer patterns: causes and prevention;Vineis;Lancet,2014

2. An appeal to world leaders: stop cancer now;Cavalli;Lancet,2013

3. Cancer survival: global surveillance will stimulate health policy and improve equity;Coleman;Lancet,2014

4. International symposium on end results of cancer therapy (NCI monograph 15),1964

Cited by 1867 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Fascinating Effects of Flavonoids on Lung Cancer: A Review;Current Nutrition & Food Science;2024-12

2. LncRNA DNAH17-AS1 promotes gastric cancer proliferation and radioresistance by sponging miR-202-3p to upregulate ONECUT2;Discover Oncology;2024-09-12

3. Breast cancer survival analysis in the Republic of Mauritius by age, stage at diagnosis and molecular subtype: A retrospective cohort study;International Journal of Cancer;2024-09-07

4. Exploring a method for extracting concerns of multiple breast cancer patients in the domain of patient narratives using BERT and its optimization by domain adaptation using masked language modeling;PLOS ONE;2024-09-06

5. Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer;Molecular Therapy: Oncology;2024-09